Glenmark Pharmaceuticals consolidated net profit declines 78.05% in the December 2017 quarter
Sales decline 11.83% to Rs 2171.51 crore
Net profit of Glenmark Pharmaceuticals declined 78.05% to Rs 104.74 crore in the quarter ended December 2017 as against Rs 477.10 crore during the previous quarter ended December 2016. Sales declined 11.83% to Rs 2171.51 crore in the quarter ended December 2017 as against Rs 2462.95 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales2171.512462.95 -12 OPM %14.8631.06 -PBDT229.06717.85 -68 PBT153.67655.33 -77 NP104.74477.10 -78Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 09 2018 | 4:17 PM IST